Cargando…

Clinical utility of plasma cell-free DNA in gliomas

Noninvasive molecular profiling of tumors using plasma-based next-generation sequencing (NGS) is increasingly used to aid in diagnosis, treatment selection, and disease monitoring in oncology. In patients with glioma, however, the plasma cell-free DNA (cfDNA) tumor fraction, defined as the fractiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carpenter, Erica L, Bagley, Stephen J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650462/ https://www.ncbi.nlm.nih.gov/pubmed/36380864 http://dx.doi.org/10.1093/noajnl/vdac014

Ejemplares similares

Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma
por: Bagley, Stephen J, et al.
Publicado: (2021)

Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma
por: Friedman, Joshua S, et al.
Publicado: (2022)

A hitchhiker’s guide to cell-free DNA biology
por: Mouliere, Florent
Publicado: (2022)

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
por: Nabavizadeh, Seyed Ali, et al.
Publicado: (2020)

MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
por: Satomi, Kaishi, et al.
Publicado: (2021)

ECOA-10. Integrated genomic and clinical analysis of BRAF-mutated glioma in adults
por: Langat, Pinky, et al.
Publicado: (2021)

Utility and delivery of behavioural interventions to prevent sexually transmitted infections
por: Aral, Sevgi O
Publicado: (2011)

CLRM-07 A MULTIVARIATE RETROSPECTIVE ANALYSIS OF 159 PATIENTS WITH HIGH-GRADE GLIOMAS: OVERALL SURVIVAL, PROGRESSION-FREE SURVIVAL, AND PROGNOSTIC FACTORS
por: Liu, Shiyu, et al.
Publicado: (2022)

NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation
por: Lobón-Iglesias, María Jesús, et al.
Publicado: (2019)

Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
por: Mouliere, Florent, et al.
Publicado: (2021)

Anticipating the Future: How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

68. FRAMELESS, VAULT-FREE RADIOSURGERY: INITIAL CLINICAL EXPERIENCE WITH THE ZAP-X STEREOTACTIC SYSTEM
por: Flores, Nicholas, et al.
Publicado: (2020)

Decoding vesicle-based precision oncology in gliomas
por: Batool, Syeda Maheen, et al.
Publicado: (2022)

Advances in molecular biomarkers and liquid biopsy in gliomas
por: Mathios, Dimitrios, et al.
Publicado: (2022)

The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study
por: Ita, Michael Itak, et al.
Publicado: (2021)

ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas
por: Muragaki, Yoshihiro, et al.
Publicado: (2020)

MPC-2 Clinical course and prognosis of lower-grade glioma, IDH wildtype and pTERT mutant
por: Takahashi, Yoshinobu, et al.
Publicado: (2021)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

DDRE-21. THE FUNCTION OF MITOCHONDRIAL OSMR IN GLIOMA STEM CELL RESPIRATION AND GLIOBLASTOMA PATHOGENESIS
por: Jahani-Asl, Arezu, et al.
Publicado: (2021)

SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA
por: Odia, Yazmin, et al.
Publicado: (2022)

Plasma Cell‐Free DNA Genotyping: From an Emerging Concept to a Standard‐of‐Care Tool in Metastatic Non‐Small Cell Lung Cancer
por: Gray, Jhanelle, et al.
Publicado: (2021)

Noninvasive approaches to detect methylation-based markers to monitor gliomas
por: Noushmehr, Houtan, et al.
Publicado: (2022)

SYST-02 PHASE ⅡB CLINICAL TRIAL OF NEOADJUVANT CHEMOTHERAPY REVERSING GLIOMA STEM CELLS CHEMORESISTANCE IN NEWLY DIAGNOSED GBM WITH MGMT PROMOTER UNMETHYLATION
por: Dong, Jun, et al.
Publicado: (2022)

Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives
por: Shihadeh, Alan, et al.
Publicado: (2015)

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults
por: Takeshima, Yuki, et al.
Publicado: (2021)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021)

FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2021)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

The Diagnostic Utility of Induced Sputum Microscopy and Culture in Childhood Pneumonia
por: Murdoch, David R., et al.
Publicado: (2017)

TB-8 Genetic and molecular properties of long-term proliferating tumorsphere -forming glioma derived cells
por: Kijima, Noriyuki, et al.
Publicado: (2021)

OTME-23. Single-cell transcriptomic and epigenomic immune landscape of isocitrate dehydrogenase stratified human gliomas
por: Gupta, Pravesh, et al.
Publicado: (2021)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

Ensuring Quality in AFRINEST and SATT: Clinical Standardization and Monitoring
por: Wall, Stephen N., et al.
Publicado: (2013)

CBMS-7 IGF1/N-cadherin/Clusterin signaling axis mediates adaptive radioresistance of glioma stem cells
por: Osuka, Satoru, et al.
Publicado: (2021)

CLRM-06 PROSPECTIVE CLINICAL STUDY OF CONVENTIONALLY FRACTIONATED CONCURRENT CHEMORADIOTHERAPY AND HYPOFRACTIONATED CONCURRENT CHEMORADIOTHERAPY AFTER THE SURGERY OF HIGH-GRADE GLIOMAS
por: Weiyan, Shi
Publicado: (2022)

COT-1 Clinical Questions and Answers about Glioma-Related Epilepsy (GRE): Real-world data in Wakayama Medical University Hospital
por: Fukai, Junya, et al.
Publicado: (2021)

Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis
por: Gutierrez-Rodrigues, Fernanda, et al.
Publicado: (2021)

IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
por: Akasaki, Yasuharu, et al.
Publicado: (2021)

BSCI-20 STING EPIGENETIC SILENCING IN GLIOMAS CAN BE RESCUED BY METHYLTRANSFERASE INHIBITION: IMPLICATIONS FOR NOVEL THERAPEUTIC APPROACHES
por: Low, Justin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cm8uvs6gi2bibpqm7eqjpakj69